SCi Partners, the leading executive search and interim management talent solutions provider to Life Sciences and Healthcare, has underlined its continued growth and development strategy with the appointment of a Group Operations Director.
Industry stalwart Ian Broadway’s credentials combine in-house commercial and talent acquisition experience, from pharmaceutical giants Pfizer, Johnson & Johnson and Novartis with 20 years’ experience in international Tier 1 and boutique Life Sciences recruitment consultancies.
SCi’s Chief Commercial Officer, Austin Clark, explains why Ian’s credentials will be key to the group’s ongoing development: “Together, Entrust Resource Solutions and SCi Partners have created an outstanding track record in meeting global talent shortages and demands at all levels. Our combined, agile response to the requirements wrought by the COVID-19 pandemic alone has illustrated precisely why we’re leaders in this field.
“As the Life Sciences industry continues to evolve and address new challenges, Ian brings the precise combination of operational, commercial and in-house talent acquisition experience, and insight required to continue strengthening our credentials as a Group.”
, has returned record results during the past two years, responding to a vastly changed landscape which has seen a significant increase in demand for Life Sciences and associated healthcare contractors and executives.
Ian adds: “This is an exciting time to join a recognised team with an enviable industry reputation and unique offering. Life Sciences is a buoyant sector, but one which requires a creative approach to ensure its sustainability. We are committed to supporting and developing the sector’s UK and European infrastructure.
We are poised for further growth, continuing to build close partnerships with our industry clients and supporting executives and interims throughout their careers in this field: I look forward to playing an instrumental role in the Group’s development.”